CAITLIN ROBLEDO: Open Payments
NPI 1417723362 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,300 in 69 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $796 · 2025 $1,300
Food & beverage: $1,300
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $218 |
| Novartis Pharmaceuticals Corporation | 16 | $204 |
| Boston Scientific Corporation | 6 | $191 |
| Amgen Inc. | 10 | $144 |
| Novo Nordisk Inc | 6 | $96 |
| ABIOMED | 3 | $71 |
| GENZYME CORPORATION | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Kestra Medical Technology Services, Inc. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
Products named: LEQVIO, WATCHMAN FLX, REPATHA, FARXIGA, Wegovy, LOKELMA, FABRAZYME, Assure WCD.
Industry payments across TX — which companies pay providers there.
